Unlike injections such as GLP-1 receptor agonists or GLP-1 and GIP drugs that provide supraphysiological dosing of GLP1 and GIP, the GLP-1 activators work internally to stimulate the bodys own production
Quick Stats of the GLP-1 Nutritional Support Market Industry Value (2025): USD 4.1 billion Forecast Value (2035): USD 13 billion Global CAGR (2025 to 2035): 12.2% Leading Segment in 2025: Protein & Macronutrient Blends (~43% share) Key Growth Region: East Asia Key Players: Nestl Health Science, Abbott, Herbalife, Unjury Protein, ProCare Health, Expansion is being shaped by clinical treatment protocols and broader reimbursement for weight loss and metabolic support
Bu, T., Sun, Z., Pan, Y., Deng, X., & Yuan, G
Whether you require bulk supply, third-party manufacturing, private labeling, or export-ready injectable formulations, we are committed to supporting your pharmaceutical business growth
Duro-Castano A, England RM, Razola D, Romero E, Oteo-Vives M, Morcillo MA, et al